Damora Therapeutics (DMRA) Tax Rate Growth (1y) (2025 - 2026)

Damora Therapeutics (DMRA) Tax Rate Growth (1y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,801.52 Bn	66,801.23 Bn	-
2	Nanobiotix	1,908.00 Bn	1,907.94 Bn	-
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-
4	BeOne Medicines	472.27 Bn	467.47 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.18 Bn	114.93 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.08 Bn	61.32 Bn	3.31 Bn
7	Belite Bio	62.34 Bn	62.34 Bn	-
8	Argenx Se	55.86 Bn	50.68 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.50 Bn	34.49 Bn	959.66 Mn
10	Damora Therapeutics	1.02 Bn	821.61 Mn	-

Download Data